As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.

IVDs are essential for disease detection, personalized treatment, and public health, driving growth in the global diagnostics ...

Cancer has long been treated as a mass of rogue cells, but the real power lies in the intricate communication networks ...

A new generation of aging tests is moving out of specialist labs and into everyday life, promising to tell you how old your ...

Biotechnology is changing fast, and it feels like every week there’s something new popping up. It’s not just about new ...

Amirali Aghazadeh receives funding from Georgia Tech. When NASA scientists opened the sample return canister from the OSIRIS-REx asteroid sample mission in late 2023, they found something astonishing.

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, addressing mammography's limitations in dense breast tissue. The test achieved 92.3 ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

In many regions, doctors practice in settings with limited medical resources. Advanced tests, specialist support, and expert ...

The ability of Raman spectroscopy to identify molecular-level spectral fingerprints has made it an attractive route to diagnostic information and identification of early-stage tumors, especially in ...